Report overview
The global RAS-acting Agents market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
ACE Inhibitors Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of RAS-acting Agents include Novartis AG, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc., Sanofi S.A., Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, Takeda Pharmaceutical Company Limited and Boehringer Ingelheim GmbH, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for RAS-acting Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RAS-acting Agents. This report contains market size and forecasts of RAS-acting Agents in global, including the following market information:
Global RAS-acting Agents Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global RAS-acting Agents Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five RAS-acting Agents companies in 2023 (%)
We surveyed the RAS-acting Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RAS-acting Agents Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global RAS-acting Agents Market Segment Percentages, by Type, 2023 (%)
ACE Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Renin Inhibitors
Aldosterone Antagonists
Others (diuretics)
Global RAS-acting Agents Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global RAS-acting Agents Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global RAS-acting Agents Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global RAS-acting Agents Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RAS-acting Agents revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies RAS-acting Agents revenues share in global market, 2023 (%)
Key companies RAS-acting Agents sales in global market, 2019-2024 (Estimated), (K Units)
Key companies RAS-acting Agents sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Sanofi S.A.
Bristol-Myers Squibb Company
Daiichi Sankyo Company, Limited
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim GmbH
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of RAS-acting Agents, market overview.
Chapter 2: Global RAS-acting Agents market size in revenue and volume.
Chapter 3: Detailed analysis of RAS-acting Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RAS-acting Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global RAS-acting Agents capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
